Comparison of clinical efficacy of Propylthiouracil and Methimazole in the treatment of hyperthyroidism
DENG Li-ping1 WU Hong-mei1▲ YUE You-wei2
1.Department of Endocrine,Shenzhen Longgang Central Hospital,Guangdong Province,Shenzhen 518116,China;
2.Department of Urological Surgery,Shenzhen Longgang Central Hospital,Guangdong Province,Shenzhen 518116,China
Abstract:Objective To analyze the clinical effects of Propylthiouracil and Methimazole in the treatment of hyperthyroidism.Methods A total of 80 hyperthyroidism patients admitted to our hospital from April 2015 to March 2016 were selected as research objects,and were divided into control group and research group by random number table method,with 40 cases in each group.The control group was treated with Propylthiouracil,while the study group was treated with Methylimidazole.The total effective rate,thyroid hormone indicators,clinical indicators,liver injury incidence,rash incidence and granulocyte damage rate of the two groups were compared.Results The total effective rate of patients in the study group was higher than that in the control group,and the difference was statistically significant(P<0.05).The thyroid hormone index of patients in the study group was better than that of the control group,and the difference was statistically significant(P<0.05).The clinical indicators of patients in the study group were better than those in the control group,with statistical significance (P<0.05).The incidence of liver injury in the study group was lower than that in the control group,and the difference was statistically significant(χ2=12.462,P=0.000).There was no significant difference in the incidence of adverse reactions between the two group(χ2=0.857,P=0.355).Conclusion In the clinical treatment of patients with hyperthyroidism,both Propylthiouracil and Methimazole have a certain therapeutic effect,but the latter treatment effect is significantly higher than the former,the latter in improving the thyroid hormone index,clinical indicators are excellent in the former,it is worthy of clinical application.
邓丽萍;武红梅;乐有为. 丙硫氧嘧啶与甲巯咪唑治疗甲状腺功能亢进症的临床效果比较[J]. 中国当代医药, 2018, 25(15): 61-63转67.
DENG Li-ping;WU Hong-mei; YUE You-wei. Comparison of clinical efficacy of Propylthiouracil and Methimazole in the treatment of hyperthyroidism. 中国当代医药, 2018, 25(15): 61-63转67.
Shi G M,Xu Q,Zhu CY,et al.Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves′disease[J].J Int Med Res,2009,37(2):576-582.
Mallela MK,Strobl M,Poulsen RR,et al.Evaluation of developmental toxicity of propylthiouracil and methimazole[J].Birth Defects Res B Dev Reprod Toxico,2014,101(4):300-307.
Emiliano AB,Governale L,Parks M,et al.Shifts in propylthiouracil and methimazole prescribing practices:antithyroid drug use in the United States from 1991 to 2008[J].J Clin Endocrinol Metab,2010,95(5):2227-2233.